Welcome to our dedicated page for STANDEX INTERNATIONAL CORP/DE/ SEC filings (Ticker: SXI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on STANDEX INTERNATIONAL CORP/DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into STANDEX INTERNATIONAL CORP/DE/'s regulatory disclosures and financial reporting.
Wasatch Advisors LP reports beneficial ownership of 866,830 shares of Standex International (SXI), representing 7.2% of the outstanding common stock. Wasatch discloses sole dispositive power over all 866,830 shares and sole voting power over 625,398 shares, with no shared voting or dispositive power reported.
The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control. The report classifies Wasatch as an investment adviser, making this a public notice that a registered adviser holds a material, passive stake in the company.
Standex International Corporation's Form 144 notifies a proposed sale of 16,000 shares of common stock on the NYSE through UBS Financial Services with an approximate aggregate market value of $3,200,000, and an indicated sale date of 08/13/2025. The filing lists 12,068,262 shares outstanding, which places the proposed sale at roughly 0.13% of the outstanding common stock.
The securities were acquired by the selling person through vested restricted stock units: 4,206 shares on 08/23/2023, 6,794 shares on 09/06/2023, and 5,000 shares on 09/06/2022. The form reports Nothing to Report for sales in the past three months. Several identifying fields in the filing (for example, filer CIK and issuer name/address sections) are blank or not populated in the provided text.
Champlain Investment Partners, LLC reported beneficial ownership of 603,095 shares of Standex International common stock, equal to 5.0% of the class. The filing shows Champlain has sole dispositive power over all 603,095 shares and sole voting power over 388,520 shares, with no shared voting or dispositive authority. The filer identifies itself as an investment adviser.
The filing includes a certification that the securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control. The statement is signed by the firm's Chief Compliance Officer.
Standex International Corp. director Robin J. Davenport reported two small acquisitions of Common Stock under the company's Dividend Reinvestment Plan during the fiscal year. The filings show purchases of 1.918 shares on 02/27/2025 and 2.389 shares on 05/22/2025, recorded as acquisitions rather than open-market trades.
After these reinvestments the reporting person's direct beneficial ownership is listed as 4,057.307 shares at the end of the issuer's fiscal year. The form explicitly states these additions were made pursuant to the company's Dividend Reinvestment Plan, and the holdings are reported as direct ownership.
Standex International Corp (SXI) reported an annual Form 5 showing small, routine purchases of common stock by an officer under the companys Employee Stock Purchase Plan. The filing lists the reporting person as Arets Max and identifies the relationship as Officer: VP, Chief Information Officer. Purchases occurred on 12/31/2024 (23 shares at $158.942), 02/27/2025 (0.64 shares at $136.50), 03/31/2025 (28 shares at $137.182) and 05/22/2025 (1.714 shares at $150.035). The explanation states these acquisitions were made pursuant to the Employee Stock Purchase Plan. The filing shows 1,317.354 shares beneficially owned at the end of the issuers fiscal year ended 06/30/2025. The form is signed and dated 08/12/2025.
Standex International (SXI) – Form 4 filing dated 08/07/2025
Chief Financial Officer, Vice President & Treasurer Ademir Sarcevic reported an open-market sale of 3,047 common shares on 08/06/2025. The weighted-average price was $191.7967 per share, with individual trade prices ranging from $191.690 to $191.915. Following the transaction, Sarcevic’s directly held position decreased to 11,323 shares.
- Transaction code: “S” (sale).
- No derivative securities were involved.
- Filing made as a single reporting person; Rule 10b5-1 box not checked.
The sale represents a liquidity event by a senior executive but does not on its face indicate any change to company fundamentals. Investors may weigh the timing—shortly after fiscal year-end—against the executive’s remaining equity stake.
Standex International Corp. (SXI) filed a Form 144 indicating a proposed sale of 3,047 common shares on or about 08-06-2025 through Fidelity Brokerage Services on the NYSE. The shares originate from three restricted-stock vesting events (2,083 on 09-06-2023, 464 on 08-23-2024, and 500 on 04-01-2025) received as compensation. At the most recent market price used by the filer, the aggregate value is $584,446.61.
The notice covers approximately 0.03 % of SXI’s 12,068,262 shares outstanding, suggesting limited potential market impact. No sales were reported in the prior three months, and the filer attests to lacking undisclosed adverse information, as required by Rule 144. Relationship to the issuer and other personal details were not disclosed in the filing.